What the PMTA Backlog Means for Vape Brands

The premarket authorization process continues to shape which products can legally stay on the market, and the backlog of pending applications has real consequences for brands, retailers and the people buying from them.

Key takeaways

• Pending applications leave brands unable to plan more than a season ahead.
• Retailers carry the risk when a product disappears from the assortment.
• For consumers, the practical protection is buying from established, licensed shops.

Uncertainty slows planning

With decisions pending, brands face uncertainty about which products will ultimately be authorized. That makes long-term planning harder and pushes some companies to hedge with broader portfolios — more products, developed less deeply, so that no single decision removes their whole catalog.

That hedging has a cost. Development effort spread across a defensive range is effort not spent making any one device better.

Why it matters to the community

For adult consumers, the backlog can mean products appearing and disappearing with little warning. A flavor you have settled on may simply stop being stocked, and the replacement may not behave the same way.

Buying from established, licensed retailers is the best way to avoid disruption and counterfeit risk. When a popular product becomes hard to find, that gap is precisely where counterfeits appear.

What to watch

• Authorization decisions on high-volume disposable formats
• Enforcement activity against unauthorized products
• How retailers adjust assortments ahead of decisions rather than after

The bottom line

The backlog is a planning problem for the industry and an availability problem for everyone else. We will keep tracking it.

This is editorial coverage for adults 21+, not legal advice.

Related reading: the latest federal filing · our 2026 market outlook · state-level legislation in 2026.

Source: FDA tobacco product application metrics and reporting.